ZA983205B - Sustained release compositions and the process for their preparation - Google Patents

Sustained release compositions and the process for their preparation

Info

Publication number
ZA983205B
ZA983205B ZA983205A ZA983205A ZA983205B ZA 983205 B ZA983205 B ZA 983205B ZA 983205 A ZA983205 A ZA 983205A ZA 983205 A ZA983205 A ZA 983205A ZA 983205 B ZA983205 B ZA 983205B
Authority
ZA
South Africa
Prior art keywords
preparation
sustained release
release compositions
compositions
sustained
Prior art date
Application number
ZA983205A
Other languages
English (en)
Inventor
Marc Pellet
Chantal Roume
Original Assignee
Pharma Biotech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Biotech filed Critical Pharma Biotech
Publication of ZA983205B publication Critical patent/ZA983205B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
ZA983205A 1997-04-18 1998-04-16 Sustained release compositions and the process for their preparation ZA983205B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704837A FR2762318B1 (fr) 1997-04-18 1997-04-18 Compositions presentant une liberation prolongee et leur procede de preparation

Publications (1)

Publication Number Publication Date
ZA983205B true ZA983205B (en) 1998-10-19

Family

ID=9506092

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA983205A ZA983205B (en) 1997-04-18 1998-04-16 Sustained release compositions and the process for their preparation

Country Status (2)

Country Link
FR (1) FR2762318B1 (fr)
ZA (1) ZA983205B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2432556T3 (es) 2004-08-04 2013-12-04 Evonik Corporation Métodos para fabricar dispositivos de suministro y sus dispositivos
IT202000017191A1 (it) * 2020-07-15 2022-01-15 Xbrane Biopharma Ab Procedimento senza acqua per preparare una composizione farmaceutica per un rilascio più prolungato e controllato di triptorelina o di un suo sale

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH661206A5 (fr) * 1983-09-23 1987-07-15 Debiopharm Sa Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
US5021554A (en) * 1989-02-24 1991-06-04 Eli Lilly And Company Process for protein particle size reduction using a fluid-energy mill
GB2246514B (en) * 1990-08-01 1993-12-15 Scras Sustained release pharmaceutical compositions and the preparation of particles for use therein
DE4041563A1 (de) * 1990-12-22 1992-06-25 Sanol Arznei Schwarz Gmbh Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
DE4223169C1 (de) * 1992-07-10 1993-11-25 Ferring Arzneimittel Gmbh Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe
FR2693905B1 (fr) * 1992-07-27 1994-09-02 Rhone Merieux Procédé de préparation de microsphères pour la libération prolongée de l'hormone LHRH et ses analogues, microsphères et formulations obtenues.
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent

Also Published As

Publication number Publication date
FR2762318A1 (fr) 1998-10-23
FR2762318B1 (fr) 1999-09-17

Similar Documents

Publication Publication Date Title
SG71879A1 (en) Controlled release compositions
EP1043030A4 (fr) Compositions medicinales a liberation prolongee
EG24198A (en) Extended release formulation
HUP9901779A3 (en) Modified release multiple-units dosage composition
ZA985180B (en) 4-Haloalkyl-3-heterocyclylpyridines and 4-haloalkyl-5-heterocyclylpyrimidines process for their preparation compositions comprising them and their use as pesticides
GB9826662D0 (en) Controlled release formulation
EG23934A (en) Poroxetine controlled release compositions
SG93831A1 (en) Polimeric controlled release compositions
SG71789A1 (en) Controlled release compositions
IL135457A0 (en) Extended release formulation
GB2310860B (en) Stable release agents
IL145520A0 (en) Flame-retarding composition and process for the preparation thereof
HUP0001780A3 (en) Stabilized tibolone compositions and process for their preparation
EG24463A (en) Modified release pharmaceutical composition
ZA975703B (en) Sustained release sufentanil compositions
SG72947A1 (en) Controlled release compositions
EP0774977A4 (fr) Compositions biocides a liberation prolongee et leur utilisation
PL347269A1 (en) Controlled release fertilizer compositions and processes for the preparation thereof
ZA9810710B (en) Sustained release formulations comprising alpha-glucosidase-inhibitors
IL133877A0 (en) Controlled release fertilizer compositions and processes for the preparation thereof
GB2322867B (en) Release agent
GB9315467D0 (en) Sustained release compositions
AU7675198A (en) Sucralfate-containing composition and process for the preparation thereof
AU1063699A (en) Release compositions
ZA983205B (en) Sustained release compositions and the process for their preparation